Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
MDLN

Market Cap: $27.51B

MI

Medline Inc.

MDLN

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin25.02%

EBITDA Margin8.51%

EBIT Margin5.37%

Pre-tax Margin3.60%

Net Profit Margin2.31%

Earnings Yield2.48%

Valuation Multiples

Price / Book2.41

Price / Sales0.92

Price / Earnings37.83

PEG-1.26

Forward PEG7.11

EV / Sales1.26

EV / EBITDA14.84

EV / Operating Cash Flow18.99

EV / Free Cash Flow18.67

Price / Free Cash Flow13.58

Price / Operating Cash Flow14.00

Cash Flow & Capital

Free Cash Flow / Share$2.36

Operating Cash Flow / Share$2.32

Free Cash Flow Yield7.37%

Capex / Revenue0.11%

Capex / Operating Cash Flow1.71%

Capex / Depreciation0.05

Stock Compensation / Revenue0.10%

Dividend Payout Ratio13.89%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio4.33

Quick Ratio2.61

Cash Ratio0.86

Debt / Assets0.32

Debt / Capital0.52

Debt / Equity1.09

Long-Term Debt / Capital0.52

Debt / Market Cap45.72%

Net Debt / EBITDA4.05

Solvency Ratio0.08

Financial Leverage3.40

Efficiency & Working Capital

Asset Turnover0.76

Fixed Asset Turnover6.37

Inventory Turnover4.81

Receivables Turnover8.18

Payables Turnover21.52

Days Sales Outstanding44.63

Days Inventory Outstanding75.86

Days Payables Outstanding16.96

Operating Cycle120.49

Cash Conversion Cycle103.53

Working Capital Turnover3.39

Returns & Quality

Return on Equity5.45%

Return on Assets1.76%

Return on Invested Capital4.04%

ROCE4.96%

Return on Tangible Assets3.90%

Operating Return on Assets4.63%

Income Quality2.59

Tax Burden0.64

Interest Burden0.67

Balance Sheet & Intrinsic Metrics

Enterprise Value$37.82B

Invested Capital$35.34B

Working Capital$9.03B

Tangible Asset Value$-2.53B

Net Current Asset Value$-8.53B

Graham Number$15.65

Graham Net-Net-$14.61

Book Value / Share$22.26

Tangible Book Value / Share-$2.96

Cash / Share$3.12

Financial Health Scores

Piotroski Score8

Altman Z-Score1.99

Revenue$29.94B

EBIT$1.61B

Market Cap$27.39B

Working Capital$9.03B

Retained Earnings$182M

Total Assets$39.35B

Total Liabilities$20.27B